Cullen Frost Raises International Business Machines Stake 3.8%, Global Assets Advisory Increases 33.5%
Cullen Frost Bankers increased its IBM stake 3.8% to 88,856 shares ($25M), and Global Assets Advisory lifted holdings 33.5% to 12,044 shares ($3.4M). IBM’s Q3 EPS of $2.65 on $16.33B revenue beat forecasts by $0.20, prompting analysts to boost price targets to $360.
1. Institutional Investors Increase Stake
In the third quarter, Cullen Frost Bankers Inc. expanded its position in International Business Machines Corporation by purchasing an additional 3,227 shares, bringing its total holdings to 88,856 shares. This 3.8% increase elevated the firm’s exposure to the technology company to approximately $25.07 million, according to its most recent Form 13F filing with the Securities and Exchange Commission. Global Assets Advisory LLC also ramped up its stake by 33.5%, adding 3,024 shares to hold 12,044 shares valued at $3.40 million, making IBM its 17th largest portfolio position. Overall, institutional ownership accounts for 58.96% of IBM’s outstanding shares, reflecting continued confidence from major asset managers.
2. Q3 Earnings and Revenue Growth
For the quarter ended October 22nd, IBM reported adjusted earnings per share of $2.65, surpassing consensus estimates by $0.20. Revenue reached $16.33 billion, up 9.1% year-over-year and exceeding analysts’ forecasts of $16.10 billion. Net margin improved to 12.09%, while return on equity climbed to 37.76%, underpinned by robust performance in cloud computing and software services. IBM’s current fiscal guidance projects full-year diluted earnings of approximately 10.78 per share, signaling solid operational momentum across its strategic segments.
3. Analyst Ratings and Targets
Eleven major brokerages have issued new or updated reports on IBM since October. Royal Bank of Canada upgraded its outlook to “outperform” and raised its target to $350, while Jefferies Financial Group moved to a “buy” rating with a $360 objective. BMO Capital Markets and Bank of America both adjusted their targets higher to $305 and $335, respectively, maintaining “market perform” and “buy” stances. Conversely, UBS Group reiterated a “sell” recommendation, and Morgan Stanley set an “equal weight” rating with a $252 target. Of the 19 analysts covering the stock, 12 rate it a buy, five a hold, one a sell and one a strong buy, underscoring a moderate buy consensus across the street.
4. Balance Sheet and Valuation Metrics
IBM’s balance sheet shows a debt-to-equity ratio of 1.97, a current ratio of 0.93 and a quick ratio of 0.89, reflecting manageable leverage alongside solid liquidity. The company’s market capitalization stands at $273.35 billion, with a price-to-earnings ratio of 34.98 and a price/earnings-to-growth ratio of 2.83. Shares have traded between a 52-week low of $214.50 and a high of $324.90, while the 50-day and 200-day moving averages rest at $302.13 and $282.63, respectively, providing key technical reference points for investors.